Indian academy recommends whole cell pertussis vaccine for primary vaccinationBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7059 (Published 25 November 2013) Cite this as: BMJ 2013;347:f7059
- Cheryl Travasso
The Indian Academy of Pediatrics has recommended the whole cell pertussis vaccine over the acellular version for primary vaccination, contrary to the situation in many developed countries, which have shifted to acellular vaccine.1
Despite high vaccination coverage, pertussis remains an important cause of infant mortality in India. The introduction of whole cell vaccines in the 1960s and 1970s led to a dramatic reduction in incidence and mortality across the world. However, some minor adverse reactions, such as redness, swelling, and fever, prompted a shift in some industrialised countries to the acellular vaccine. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial